Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects with Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML
- Status
- UNKNOWN
- Phase
- PHASE3
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
- Status
- RECRUITING
- Phase
- PHASE2
MargheRITA (Remote Intelligence for Therapeutic Adherence)
- Status
- COMPLETED
- Phase
- NA
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
- Status
- RECRUITING
- Phase
- NA
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
- Status
- RECRUITING
- Phase
- PHASE1
Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
- Status
- TERMINATED
- Phase
- PHASE1
Managed Access Programs for PKC412, Midostaurin
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
- Status
- COMPLETED
- Phase
- N/A
Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- N/A
Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE3